Related Experiment Video

Updated: Mar 5, 2026

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
13:35

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction

Published on: May 17, 2024

4.6K

3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)

F Cardoso, A Costa, E Senkus

    Annals of Oncology : Official Journal of the European Society for Medical Oncology
    |March 23, 2017
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
    03:07

    Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial

    Published on: August 19, 2025

    1.3K
    Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
    06:03

    Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

    Published on: February 6, 2020

    7.2K

    Related Experiment Videos

    Last Updated: Mar 5, 2026

    Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
    13:35

    Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction

    Published on: May 17, 2024

    4.6K
    Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
    03:07

    Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial

    Published on: August 19, 2025

    1.3K
    Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
    06:03

    Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

    Published on: February 6, 2020

    7.2K

    Related Concept Videos

    Treatment Resistant Cancers02:56

    Treatment Resistant Cancers

    3.8K
    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
    3.8K

    Articles linked to this work by shared authors, journal, and citation graph.

    An autoregulatory feedback loop directs the localized expression of the Drosophila CPEB protein Orb in the developing oocyte.

    Development (Cambridge, England)·2001

    [Prognosis and risk evaluation of postoperative coronary patients (PERISCOP). Methodology and study population characteristics].

    Archives des maladies du coeur et des vaisseaux·2001

    Expression of apoptosis-related markers and clinical outcome in patients with advanced colorectal cancer.

    British journal of cancer·2001

    Effect of nitric oxide donors on the central nervous system--nitroglycerin studies in the rat.

    Functional neurology·2001

    [The experience of menstruation and its disorders in 603 women using contraception in 1999].

    Gynecologie, obstetrique & fertilite·2001

    Headache in the Diagnosis-Related Groups (DRG) era: management and appropriateness of admission.

    Functional neurology·2001

    Ovarian reserve as a measure of adjuvant chemotherapy benefit in hormone receptor positive (HR-positive), HER2-negative, node-positive breast cancer in SWOG S1007 (RxPONDER).

    Annals of oncology : official journal of the European Society for Medical Oncology·2026

    Therapeutic targeting of RAS-mediated resistance in oncogene-driven lung cancer.

    Annals of oncology : official journal of the European Society for Medical Oncology·2026

    Eight-year outcomes of testosterone suppression plus enzalutamide or a non-steroidal anti-androgen for metastatic, hormone-sensitive prostate cancer (ENZAMET; ANZUP 1304).

    Annals of oncology : official journal of the European Society for Medical Oncology·2026

    Nivolumab plus chemotherapy or ipilimumab versus chemotherapy as first-line treatment for advanced esophageal squamous cell carcinoma: 5-year follow-up results from CheckMate 648.

    Annals of oncology : official journal of the European Society for Medical Oncology·2026

    SKYSCRAPER-03: A Phase III Study of Tiragolumab Plus Atezolizumab Versus Durvalumab in Locally Advanced, Unresectable, Stage III NSCLC After Platinum-Based Concurrent Chemoradiation.

    Annals of oncology : official journal of the European Society for Medical Oncology·2026

    A multimodal deep learning model for preoperative prediction of post-operative complications in gastric cancer.

    Annals of oncology : official journal of the European Society for Medical Oncology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us